“IN SILICO STUDY OF VANILLIN SCHIFF BASES AS PROTO ONCOGENE TYROSINE KINASE INHIBITORS OF CHRONIC MYELOID LEUKEMIA”. Frontier in Medical and Health Research 3, no. 10 (December 18, 2025): 570–577. Accessed November 10, 2026. https://fmhr.net/index.php/fmhr/article/view/1765.